Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127886) titled 'Efficacy and Safety of Apixaban for the Prevention of Venous Thromboembolism After Radiofrequency Ablation of the Great Saphenous Vein: A Prospective, Multicenter, Randomized Controlled Trial' on July 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine
Condition:
Chronic venous insufficiency (CVI)
Intervention:
Anticoagulation group:apixaban
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Anticoagulation group:410;placebo group:410;
Countries of Re...